Roche expands cyclospora testing portfolio to support U.S. public health response |
Roche has launched two new, real-time PCR tests to detect cyclospora, a diarrhea-causing infection, to help meet diverse…
New Bern parents react to Trump order calling for separate childhood vaccines
NEW BERN, N.C. (WITN) – President Donald Trump signed an executive order Monday pushing to separate the measles,…
FDA approves Pluvicto for PSMA+ metastatic hormone-sensitive prostate cancer (mHSPC), advancing potential new standard of care across metastatic disease
Pluvicto now approved across PSMA+ metastatic prostate cancer, nearly doubling eligible patient population PSMAddition updated results show Pluvicto…
Test that could identify signs of Alzheimer’s disease 20 years earlier greenlit for trials
The ability to test for signs of Alzheimer’s disease decades earlier could be a step closer with a…
New Novartis data at ERA 2026 advance scientific understanding of kidney disease and reinforce portfolio strength
Late-breaking Phase III IgAN data for Vanrafia ALIGN and Fabhalta APPLAUSE-IgAN studies to be presented124-week Phase I/II zigakibart…
Roche launches the Liver Disease Panel, the first suite of certified algorithms to support Chronic Liver Disease management
Roche introduces the first comprehensive library of certified healthcare algorithms to support chronic liver disease (CLD) management The Liver…
Brand New: News from Nestle, TaoKaeNoi, SAMBAZON and more big names
Nestlé predicts filtered coffee will see a surge that reflects rising consumer demand for cleaner flavours and innovative…
Novartis Shares Bolstered by Kidney Disease Therapy Milestone
Novartis’s Fabhalta shows 49.3% slower kidney decline in IgA nephropathy trial, securing FDA Priority Review and bolstering its…
The Swiss medical breakthrough that cured the ‘cretins of the Alps’
Cretinism was widespread throughout the Alps, as demonstrated by this Austrian illustration from 1819 by Franz Sartori, entitled…
Roche receives CE mark for first IVD immunoassay blood test to identify carriers of ApoE4, a genetic variant present in up to 60% of patients diagnosed with Alzheimer’s disease
The Elecsys ApoE4 test is the first CE marked in-vitro diagnostic immunoassay to identify individuals carrying the ApoE4…
New England Journal of Medicine publishes phase III ALLEGORY data showing Roche’s Gazyva/Gazyvaro significantly reduces disease activity in the most common form of lupus
Over three quarters of people on Gazyva/Gazyvaro plus standard therapy achieved at least a four-point improvement in SRI-4,…
Over 1,000 cyclists ride in Bike MS: Historic New Bern
New Bern, N.C. (WITN) – New Bern hosted their annual historic Bike MS ride on Saturday and Sunday,…